These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 37239978)

  • 21. The OM-85 bacterial lysate inhibits SARS-CoV-2 infection of epithelial cells by downregulating SARS-CoV-2 receptor expression.
    Pivniouk V; Pivniouk O; DeVries A; Uhrlaub JL; Michael A; Pivniouk D; VanLinden SR; Conway MY; Hahn S; Malone SP; Ezeh P; Churko JM; Anderson D; Kraft M; Nikolich-Zugich J; Vercelli D
    J Allergy Clin Immunol; 2022 Mar; 149(3):923-933.e6. PubMed ID: 34902435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated FiO
    Myti D; Gunjak M; Casado F; Khaghani Raziabad S; Nardiello C; Vadász I; Herold S; Pryhuber G; Seeger W; Morty RE
    Am J Physiol Lung Cell Mol Physiol; 2020 Oct; 319(4):L670-L674. PubMed ID: 32878480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of SARS-CoV-2-related receptors in cells of the neurovascular unit: implications for HIV-1 infection.
    Torices S; Cabrera R; Stangis M; Naranjo O; Fattakhov N; Teglas T; Adesse D; Toborek M
    J Neuroinflammation; 2021 Jul; 18(1):167. PubMed ID: 34325716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Common Medications on the Expression of SARS-CoV-2 Entry Receptors in Kidney Tissue.
    Saheb Sharif-Askari N; Saheb Sharif-Askari F; Alabed M; Tayoun AA; Loney T; Uddin M; Senok A; Al Heialy S; Hamoudi R; Kashour T; Alsheikh-Ali A; Hamid Q; Halwani R
    Clin Transl Sci; 2020 Nov; 13(6):1048-1054. PubMed ID: 32799423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity.
    Cantuti-Castelvetri L; Ojha R; Pedro LD; Djannatian M; Franz J; Kuivanen S; van der Meer F; Kallio K; Kaya T; Anastasina M; Smura T; Levanov L; Szirovicza L; Tobi A; Kallio-Kokko H; Österlund P; Joensuu M; Meunier FA; Butcher SJ; Winkler MS; Mollenhauer B; Helenius A; Gokce O; Teesalu T; Hepojoki J; Vapalahti O; Stadelmann C; Balistreri G; Simons M
    Science; 2020 Nov; 370(6518):856-860. PubMed ID: 33082293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypoxia modifies levels of the SARS-CoV-2 cell entry proteins, angiotensin-converting enzyme 2, and furin in fetal human brain endothelial cells.
    Mughis H; Lye P; Matthews SG; Bloise E
    Am J Obstet Gynecol MFM; 2023 Oct; 5(10):101126. PubMed ID: 37562534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical and Transcriptional Analysis of SARS-CoV-2 Entry Factors and Renin-Angiotensin-Aldosterone System Components in Lethal COVID-19.
    Haslbauer JD; Stalder A; Zinner C; Bassetti S; Mertz KD; Went P; Matter M; Tzankov A
    Pathobiology; 2022; 89(3):166-177. PubMed ID: 34915500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human gene polymorphisms and their possible impact on the clinical outcome of SARS-CoV-2 infection.
    Hashemi SMA; Thijssen M; Hosseini SY; Tabarraei A; Pourkarim MR; Sarvari J
    Arch Virol; 2021 Aug; 166(8):2089-2108. PubMed ID: 33934196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-142 Targets TIM-1 in Human Endothelial Cells: Potential Implications for Stroke, COVID-19, Zika, Ebola, Dengue, and Other Viral Infections.
    Kansakar U; Gambardella J; Varzideh F; Avvisato R; Jankauskas SS; Mone P; Matarese A; Santulli G
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The contrasting role of nasopharyngeal angiotensin converting enzyme 2 (ACE2) transcription in SARS-CoV-2 infection: A cross-sectional study of people tested for COVID-19 in British Columbia, Canada.
    Nikiforuk AM; Kuchinski KS; Twa DDW; Lukac CD; Sbihi H; Basham CA; Steidl C; Prystajecky NA; Jassem AN; Krajden M; Patrick DM; Sekirov I
    EBioMedicine; 2021 Apr; 66():103316. PubMed ID: 33819740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COVID-19 and Long COVID: Disruption of the Neurovascular Unit, Blood-Brain Barrier, and Tight Junctions.
    Kempuraj D; Aenlle KK; Cohen J; Mathew A; Isler D; Pangeni RP; Nathanson L; Theoharides TC; Klimas NG
    Neuroscientist; 2024 Aug; 30(4):421-439. PubMed ID: 37694571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Co-Expression and Localization of Angiotensin-Converting Enzyme-2 (ACE2) and the Transmembrane Serine Protease 2 (TMPRSS2) in Paranasal Ciliated Epithelium of Patients with Chronic Rhinosinusitis.
    Kawasumi T; Takeno S; Ishino T; Ueda T; Hamamoto T; Takemoto K; Horibe Y; Takashi O
    Am J Rhinol Allergy; 2022 May; 36(3):313-322. PubMed ID: 34989246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ACE2 Receptor and TMPRSS2 Protein Expression Patterns in the Human Brainstem Reveal Anatomical Regions Potentially Vulnerable to SARS-CoV-2 Infection.
    Emmi A; Tushevski A; Sinigaglia A; Barbon S; Sandre M; Stocco E; Macchi V; Antonini A; Barzon L; Porzionato A; De Caro R
    ACS Chem Neurosci; 2023 Jun; 14(11):2089-2097. PubMed ID: 37172190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infection of Brain Pericytes Underlying Neuropathology of COVID-19 Patients.
    Bocci M; Oudenaarden C; Sàenz-Sardà X; Simrén J; Edén A; Sjölund J; Möller C; Gisslén M; Zetterberg H; Englund E; Pietras K
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hydroxychloroquine treatment on SARS-CoV-2 receptor ACE2, TMPRSS2 and NRP1 expression in human primary pterygium and conjunctival cells.
    Yao Y; Ma D; Xu Y; Yuan XL; Liang JJ; Chen SL; Jhanji V; Ng TK
    Exp Eye Res; 2022 Jan; 214():108864. PubMed ID: 34826419
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Hu S; Hu Z; Qin J; Lin C; Jiang X
    Aging (Albany NY); 2021 Jun; 13(12):15770-15784. PubMed ID: 34168096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics of Angiotensin I-converting enzyme 2, type II transmembrane serine protease 2 and 4 in tree shrew indicate it as a potential animal model for SARS-CoV-2 infection.
    Li N; Gu W; Lu C; Sun X; Tong P; Han Y; Wang W; Dai J
    Bioengineered; 2021 Dec; 12(1):2836-2850. PubMed ID: 34227905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.
    Li K; Meyerholz DK; Bartlett JA; McCray PB
    mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.
    Essalmani R; Jain J; Susan-Resiga D; Andréo U; Evagelidis A; Derbali RM; Huynh DN; Dallaire F; Laporte M; Delpal A; Sutto-Ortiz P; Coutard B; Mapa C; Wilcoxen K; Decroly E; Nq Pham T; Cohen ÉA; Seidah NG
    J Virol; 2022 Apr; 96(8):e0012822. PubMed ID: 35343766
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Sun TK; Huang WC; Sun YW; Deng JS; Chien LH; Chou YN; Jiang WP; Lin JG; Huang GJ
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.